1. Circulating Biomarkers of Colorectal Cancer (CRC)—Their Utility in Diagnosis and Prognosis
    Marta Łukaszewicz-Zając et al, 2021, Journal of Clinical Medicine CrossRef
  2. CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production
    Wei Zeng et al, 2014, Experimental and Molecular Pathology CrossRef
  3. Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis
    Kensuke Yamamura et al, 2016, Clinical Cancer Research CrossRef
  4. MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications
    Ashlee M. Strubberg et al, 2017, Disease Models & Mechanisms CrossRef
  5. Biphasic Ccl20 regulation by Toll-like receptor 9 through the activation of ERK-AP-1 and non-canonical NF-κB signaling pathways
    Pujarini Dutta et al, 2017, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
  6. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview
    Vilma Oliveira Frick, 2016, World Journal of Gastroenterology CrossRef
  7. CCL20 mediates RANK/RANKL-induced epithelial-mesenchymal transition in endometrial cancer cells
    Yao Liu et al, 2016, Oncotarget CrossRef
  8. miR-21 Promotes Human Nucleus Pulposus Cell Proliferation through PTEN/AKT Signaling
    Hongzhe Liu et al, 2014, International Journal of Molecular Sciences CrossRef
  9. CCL20 Displays Antimicrobial Activity AgainstCryptosporidium parvum, but Its Expression Is Reduced During Infection in the Intestine of Neonatal Mice
    William Guesdon et al, 2015, Journal of Infectious Diseases CrossRef
  10. Chemokine ligand 20 enhances progression of hepatocellular carcinomaviaepithelial-mesenchymal transition
    Ke-Zhu Hou, 2015, World Journal of Gastroenterology CrossRef
  11. Chemokines—What Is Their Role in Colorectal Cancer?
    Sara Pączek et al, 2020, Cancer Control CrossRef
  12. Regulation of host epithelial responses toCryptosporidiuminfection by microRNAs
    Z. Ming et al, 2017, Parasite Immunology CrossRef
  13. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial–mesenchymal transition
    Xian-Shuo Cheng et al, 2014, Cancer Letters CrossRef
  14. The Role of non-coding RNAs in colorectal cancer, with a focus on its autophagy
    Li Chen et al, 2021, Pharmacology & Therapeutics CrossRef
  15. NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression
    Rosa Mistica C. Ignacio et al, 2016, PLOS ONE CrossRef
  16. Phenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord blood
    Zhen Zhang et al, 2015, Cytotherapy CrossRef
  17. Development and endoscopic appearance of colorectal tumors are characterized by the expression profiles of miRNAs
    Yoshihito Nakagawa et al, 2018, Medical Molecular Morphology CrossRef
  18. Role of microRNAs in intervertebral disc degeneration (Review)
    Fengguang Yang et al, 2021, Experimental and Therapeutic Medicine CrossRef
  19. Circ_0026344 restrains metastasis of human colorectal cancer cells via miR-183
    Tao Shen et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  20. The role of microRNA-21 in the onset and progression of cancer
    Ashutosh Singh et al, 2021, Future Medicinal Chemistry CrossRef
  21. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation
    XiangJian Chen et al, 2015, Oncotarget CrossRef
  22. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma
    Xiang Li et al, 2016, World Journal of Gastroenterology CrossRef